{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T14:36:52Z","timestamp":1722609412528},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,8,16]],"date-time":"2006-08-16T00:00:00Z","timestamp":1155686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Individuals heterozygous for germline <jats:italic>ATM<\/jats:italic> mutations have been reported to have an increased risk for breast cancer but the role for <jats:italic>ATM<\/jats:italic> genetic variants for breast cancer risk has remained unclear. Recently, a common <jats:italic>ATM<\/jats:italic> variant, <jats:italic>ATMivs38<\/jats:italic> -8T&gt;C in cis with the <jats:italic>ATMex39<\/jats:italic> 5557G&gt;A (D1853N) variant, was suggested to associate with bilateral breast cancer among familial breast cancer patients from Northern Finland. We have here evaluated the 5557G&gt;A and ivs38-8T&gt;C variants in an extensive case-control association analysis. We also aimed to investigate whether there are other <jats:italic>ATM<\/jats:italic> mutations or variants contributing to breast cancer risk in our population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Two common <jats:italic>ATM<\/jats:italic> variants, 5557G&gt;A and ivs38-8T&gt;C, previously suggested to associate with bilateral breast cancer, were genotyped in an extensive set of 786 familial and 884 unselected breast cancer cases as well as 708 healthy controls. We also screened the entire coding region and exon-intron boundaries of the <jats:italic>ATM<\/jats:italic> gene in 47 familial breast cancer patients and constructed haplotypes of the patients. The identified variants were also evaluated for increased breast cancer risk among additional breast cancer cases and controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Neither of the two common variants, 5557G&gt;A and ivs38-8T&gt;C, nor any haplotype containing them, was significantly associated with breast cancer risk, bilateral breast cancer or multiple primary cancers in any of the patient groups or subgoups. Three rare missense alterations and one intronic change were each found in only one patient of over 250 familial patients studied and not among controls. The fourth missense alteration studied further was found with closely similar frequencies in over 600 familial cases and controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Altogether, our results suggest very minor effect, if any, of <jats:italic>ATM<\/jats:italic> genetic variants on familial breast cancer in Southern Finland. Our results do not support association of the 5557G&gt;A or ivs38-8T&gt;C variant with increased breast cancer risk or with bilateral breast cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-6-209","type":"journal-article","created":{"date-parts":[[2006,8,16]],"date-time":"2006-08-16T18:14:44Z","timestamp":1155752084000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ATM variants and cancer risk in breast cancer patients from Southern Finland"],"prefix":"10.1186","volume":"6","author":[{"given":"Johanna","family":"Tommiska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Kilpivaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hege","family":"Edvardsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vessela","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anitta","family":"Tamminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Blomqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lise","family":"B\u00f8rresen-Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,16]]},"reference":[{"key":"561_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrc1011","volume":"3","author":"Y Shiloh","year":"2003","unstructured":"Shiloh Y: ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003, 3: 155-168. 10.1038\/nrc1011.","journal-title":"Nat Rev Cancer"},{"key":"561_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995, 268: 1749-1753.","journal-title":"Science"},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.immunol.15.1.177","volume":"15","author":"MF Lavin","year":"1997","unstructured":"Lavin MF, Shiloh Y: The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997, 15: 177-202. 10.1146\/annurev.immunol.15.1.177.","journal-title":"Annu Rev Immunol"},{"key":"561_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/B:JOMG.0000048772.92326.a1","volume":"9","author":"KK Khanna","year":"2004","unstructured":"Khanna KK, Chenevix-Trench G: ATM and genome maintenance: defining its role in breast cancer susceptibility. J Mammary Gland Biol Neoplasia. 2004, 9: 247-262. 10.1023\/B:JOMG.0000048772.92326.a1.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"561_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJM198705213162101","volume":"316","author":"M Swift","year":"1987","unstructured":"Swift M, Reitnauer PJ, Morrell D, Chase CL: Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med. 1987, 316: 1289-1294.","journal-title":"N Engl J Med"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","volume":"325","author":"M Swift","year":"1991","unstructured":"Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991, 325: 1831-1836.","journal-title":"N Engl J Med"},{"key":"561_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","volume":"93","author":"JH Olsen","year":"2001","unstructured":"Olsen JH, Hahnemann JM, B\u00f8rresen-Dale AL, Br\u00f8ndum-Nielsen K, Hammarstr\u00f6m L, Kleinerman R, K\u00e4\u00e4ri\u00e4inen H, L\u00f6nnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD, Tucker M: Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst. 2001, 93: 121-127. 10.1093\/jnci\/93.2.121.","journal-title":"J Natl Cancer Inst"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF: Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 2005, 97: 813-822.","journal-title":"J Natl Cancer Inst"},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.bjc.6602658","volume":"93","author":"JH Olsen","year":"2005","unstructured":"Olsen JH, Hahnemann JM, Borresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarstrom L, Robsahm TE, Kaariainen H, Bregard A, Brondum-Nielsen K, Yuen J, Tucker M: Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br J Cancer. 2005, 93: 260-265. 10.1038\/sj.bjc.6602658.","journal-title":"Br J Cancer"},{"key":"561_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.20101","volume":"42","author":"E Cavaciuti","year":"2005","unstructured":"Cavaciuti E, Lauge A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N: Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer. 2005, 42: 1-9. 10.1002\/gcc.20101.","journal-title":"Genes Chromosomes Cancer"},{"key":"561_CR11","first-page":"3325","volume":"63","author":"YR Thorstenson","year":"2003","unstructured":"Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ: Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 2003, 63: 3325-3333.","journal-title":"Cancer Res"},{"key":"561_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ijc.20996","volume":"116","author":"K Heikkinen","year":"2005","unstructured":"Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Nieminen P, Winqvist R: Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer. 2005, 116: 69-72. 10.1002\/ijc.20996.","journal-title":"Int J Cancer"},{"key":"561_CR13","first-page":"8717","volume":"63","author":"S Angele","year":"2003","unstructured":"Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J: ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res. 2003, 63: 8717-8725.","journal-title":"Cancer Res"},{"key":"561_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0959-8049(00)00093-9","volume":"36","author":"H Eerola","year":"2000","unstructured":"Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H, Familial breast cancer in Southern Finland: How prevalent are breast cancer families and can we trust the family history reported by the patients?. Eur J Cancer. 2000, 36: 1143-1148. 10.1016\/S0959-8049(00)00093-9.","journal-title":"Eur J Cancer"},{"key":"561_CR15","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/hmg\/6.13.2309","volume":"6","author":"P Vehmanen","year":"1997","unstructured":"Vehmanen P, Friedman L, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrj\u00e4koski K, Pyrh\u00f6nen S, Kallioniemi O, Muhonen T, Luce M, Frank T, Nevanlinna H: Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: strong evidence for additional susceptibility genes. Hum Mol Genet. 1997, 6: 2309-2315. 10.1093\/hmg\/6.13.2309.","journal-title":"Hum Mol Genet"},{"key":"561_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1054\/bjoc.2000.1626","volume":"84","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H: A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer. 2001, 84: 704-708. 10.1054\/bjoc.2000.1626.","journal-title":"Br J Cancer"},{"key":"561_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet. 2002, 71: 432-438. 10.1086\/341943.","journal-title":"Am J Hum Genet"},{"key":"561_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","volume":"92","author":"K Syrj\u00e4koski","year":"2000","unstructured":"Syrj\u00e4koski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst. 2000, 92: 1529-1531. 10.1093\/jnci\/92.18.1529.","journal-title":"J Natl Cancer Inst"},{"key":"561_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ijc.20638","volume":"113","author":"O Kilpivaara","year":"2005","unstructured":"Kilpivaara O, Bartkova J, Eerola H, Syrjakoski K, Vahteristo P, Lukas J, Blomqvist C, Holli K, Heikkila P, Sauter G, Kallioniemi OP, Bartek J, Nevanlinna H: Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer. 2005, 113: 575-580. 10.1002\/ijc.20638.","journal-title":"Int J Cancer"},{"key":"561_CR20","first-page":"7608","volume":"61","author":"T Dork","year":"2001","unstructured":"Dork T, Bendix R, Bremer M, Rades D, Klopper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH: Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 2001, 61: 7608-7615.","journal-title":"Cancer Res"},{"key":"561_CR21","first-page":"46","volume":"52","author":"AC Syv\u00e4nen","year":"1993","unstructured":"Syv\u00e4nen AC, Sajantila A, Lukka M: Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet. 1993, 52: 46-59.","journal-title":"Am J Hum Genet"},{"key":"561_CR22","unstructured":"KBioscience. [http:\/\/www.kbioscience.co.uk]"},{"key":"561_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/humu.10206","volume":"21","author":"JL Bernstein","year":"2003","unstructured":"Bernstein JL, Teraoka S, Haile RW, B\u00f8rresen-Dale A-L, Rosenstein B, Gatti RA, Diep AT, Jansen L, Atencio D, Olsen JH, Bernstein L, Teiteilbaum SL, Thompson WD, Concannon P: Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat. 2003, 21: 542-550. 10.1002\/humu.10206.","journal-title":"Hum Mutat"},{"key":"561_CR24","unstructured":"Matthew Stephens -Software for Haplotype Estimation. [http:\/\/www.stat.washington.edu\/stephens\/software.html]"},{"key":"561_CR25","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith N, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001, 68: 978-989. 10.1086\/319501.","journal-title":"Am J Hum Genet"},{"key":"561_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/379378","volume":"73","author":"M Stephens","year":"2003","unstructured":"Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003, 73: 1162-1169. 10.1086\/379378.","journal-title":"Am J Hum Genet"},{"key":"561_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.212802","volume":"12","author":"PC Ng","year":"2002","unstructured":"Ng PC, Henikoff S: Accounting for human polymorphisms predictedto affect protein function. Genome Res. 2002, 12: 436-446. 10.1101\/gr.212802.","journal-title":"Genome Res"},{"key":"561_CR28","unstructured":"SIFT. [http:\/\/blocks.fhcrc.org\/sift\/SIFT.html]"},{"key":"561_CR29","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30: 3894-3900. 10.1093\/nar\/gkf493.","journal-title":"Nucleic Acids Res"},{"key":"561_CR30","unstructured":"PolyPhen Prediction of Functional Effect of Human nsSNPs. [http:\/\/genetics.bwh.harvard.edu\/pph\/]"},{"key":"561_CR31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.aje.a121625","volume":"99","author":"JJ Schlesselman","year":"1974","unstructured":"Schlesselman JJ: Sample Size Requirements in Cohort and Case-Control Studies of Disease. Am J Epidemiol. 1974, 99: 381-384.","journal-title":"Am J Epidemiol"},{"key":"561_CR32","unstructured":"Power Calculator. [http:\/\/calculators.stat.ucla.edu\/powercalc\/]"},{"key":"561_CR33","volume-title":"Sample Size. SISA","author":"DG Uitenbroek","year":"1997","unstructured":"Uitenbroek DG: Sample Size. SISA. 1997, [http:\/\/home.clara.net\/sisa\/samsize.htm]"},{"key":"561_CR34","unstructured":"SISA. [http:\/\/home.clara.net\/sisa\/]"},{"key":"561_CR35","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr534","volume":"4","author":"AB Spurdle","year":"2002","unstructured":"Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G, Khanna K: No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res. 2002, 4: R15-10.1186\/bcr534.","journal-title":"Breast Cancer Res"},{"key":"561_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0165-4608(03)00119-5","volume":"145","author":"SS Sommer","year":"2003","unstructured":"Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A: ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet. 2003, 145: 115-120. 10.1016\/S0165-4608(03)00119-5.","journal-title":"Cancer Genet Cytogenet"},{"key":"561_CR37","first-page":"733","volume":"12","author":"P Bretsky","year":"2003","unstructured":"Bretsky P, Haiman CA, Gilad S, Yahalom J, Grossman A, Paglin S, Van Den Berg D, Kolonel LN, Skaliter R, Henderson BE: The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev. 2003, 12: 733-738.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"561_CR38","doi-asserted-by":"crossref","unstructured":"Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P: On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer. 2006, Feb 22,","DOI":"10.1002\/ijc.21876"},{"key":"561_CR39","unstructured":"HapMap Homepage. [http:\/\/www.hapmap.org\/]"},{"key":"561_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1086\/321296","volume":"69","author":"YR Thorstenson","year":"2001","unstructured":"Thorstenson YR, Shen P, Tusher VG, Wayne TL, Davis RW, Chu G, Oefner PJ: Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet. 2001, 69: 396-412. 10.1086\/321296.","journal-title":"Am J Hum Genet"},{"key":"561_CR41","doi-asserted-by":"publisher","first-page":"R416","DOI":"10.1186\/bcr809","volume":"6","author":"RM Tamimi","year":"2004","unstructured":"Tamimi RM, Hankinson SE, Spiegelman D, Kraft P, Colditz GA, Hunter DJ: Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2004, 6: R416-422. 10.1186\/bcr809.","journal-title":"Breast Cancer Res"},{"key":"561_CR42","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1055-9965.EPI-04-0330","volume":"14","author":"KM Lee","year":"2005","unstructured":"Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D: Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005, 14: 821-825. 10.1158\/1055-9965.EPI-04-0330.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"561_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nature04226","volume":"437","author":"The International HapMap Consortium","year":"2005","unstructured":"The International HapMap Consortium: A haplotype map of the human genome. Nature. 2005, 437: 1299-1320. 10.1038\/nature04226.","journal-title":"Nature"},{"key":"561_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1098-1004(200009)16:3<232::AID-HUMU6>3.0.CO;2-L","volume":"16","author":"K Laake","year":"2000","unstructured":"Laake K, Jansen L, Hahnemann JM, Br\u00f8ndum-Nielsen K, L\u00f6nnqvist T, K\u00e4\u00e4ri\u00e4inen H, Sankila R, L\u00e4hdesm\u00e4ki A, Hammarstr\u00f6m L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, B\u00f8rresen-Dale AL: Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat. 2000, 16: 232-246. 10.1002\/1098-1004(200009)16:3<232::AID-HUMU6>3.0.CO;2-L.","journal-title":"Hum Mutat"},{"key":"561_CR45","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1086\/302746","volume":"66","author":"A Broeks","year":"2000","unstructured":"Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE, van't Veer LJ: ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet. 2000, 66: 494-500. 10.1086\/302746.","journal-title":"Am J Hum Genet"},{"key":"561_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"G Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dork T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002, 94: 205-215.","journal-title":"J Natl Cancer Inst"},{"key":"561_CR47","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/0008-5472.CAN-03-2678","volume":"64","author":"CI Szabo","year":"2004","unstructured":"Szabo CI, Schutte M, Broeks A, Houwing-Duistermaat JJ, Thorstenson YR, Durocher F, Oldenburg RA, Wasielewski M, Odefrey F, Thompson D, Floore AN, Kraan J, Klijn JG, van den Ouweland AM, Wagner TM, Devilee P, Simard J, van't Veer LJ, Goldgar DE, Meijers-Heijboer H: Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?. Cancer Res. 2004, 64: 840-843. 10.1158\/0008-5472.CAN-03-2678.","journal-title":"Cancer Res"},{"key":"561_CR48","doi-asserted-by":"publisher","first-page":"R401","DOI":"10.1186\/bcr806","volume":"6","author":"GJ Lindeman","year":"2004","unstructured":"Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL, Gardner RJ, Trainor K, Cheetham G, Suthers G, Kirk J: Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families. Breast Cancer Res. 2004, 6: R401-407. 10.1186\/bcr806.","journal-title":"Breast Cancer Res"},{"key":"561_CR49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/humu.9344","volume":"25","author":"D Thompson","year":"2005","unstructured":"Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G, KConFab Investigators: Two ATM variants and breast cancer risk. Hum Mutat. 2005, 25: 594-595. 10.1002\/humu.9344.","journal-title":"Hum Mutat"},{"key":"561_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jmg.39.3.192","volume":"39","author":"M Allinen","year":"2002","unstructured":"Allinen M, Launonen V, Laake K, Jansen L, Huusko P, Kaariainen H, Borresen-Dale AL, Winqvist R: ATM mutations in Finnish breast cancer patients. J Med Genet. 2002, 39: 192-196. 10.1136\/jmg.39.3.192.","journal-title":"J Med Genet"},{"key":"561_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ng0397-307","volume":"15","author":"MG FitzGerald","year":"1997","unstructured":"FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA: Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997, 15: 307-310. 10.1038\/ng0397-307.","journal-title":"Nat Genet"},{"key":"561_CR52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng0397-226","volume":"15","author":"DT Bishop","year":"1997","unstructured":"Bishop DT, Hopper J: AT-tributable risks?. Nat Genet. 1997, 15: 226-10.1038\/ng0397-226.","journal-title":"Nat Genet"},{"key":"561_CR53","volume-title":"The American Society of Human Genetics, 54th Annual Meeting, Toronto, Canada. Abstract 405","author":"K Heikkinen","year":"2004","unstructured":"Heikkinen K, Tommiska J, Syrjakoski K, Kere J, Allinen M, Karppinen S-M, Rapakko K, Holli K, Kallioniemi H, Nevanlinna DT, Winqvist R: Involvement of three Finnish ATM founder mutations in breast cancer susceptibility. The American Society of Human Genetics, 54th Annual Meeting, Toronto, Canada. Abstract 405. 2004"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-6-209\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-6-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:35:00Z","timestamp":1630449300000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-6-209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,16]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-6-209","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,16]]},"assertion":[{"value":"11 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"209"}}